Le pouvoir vient d’ailleurs: leadership et coopération chez les Inuits du Nunavik

por Hervé, Caroline
Publicado 2000

The how’s and what’s of vaccine reactogenicity

por Hervé, Caroline, Laupèze, Béatrice, Del Giudice, Giuseppe, Didierlaurent, Arnaud M., Tavares Da Silva, Fernanda
Publicado 2019

Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis...

por Dagnew, Alemnew F, Rausch, Debora, Hervé, Caroline, Zahaf, Toufik, Levin, Myron J, Schuind, Anne
Publicado 2020

An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine

por Pirrotta, Paola, Tavares-Da-Silva, Fernanda, Co, Maribel, Lecrenier, Nicolas, Hervé, Caroline, Stegmann, Jens-Ulrich
Publicado 2021

EVT‐701 is a novel selective and safe mitochondrial complex 1 inhibitor with potent anti‐tumor activity in models of solid cancers

por Luna Yolba, Raquel, Visentin, Virgile, Hervé, Caroline, Chiche, Johanna, Ricci, Jean‐Ehrland, Méneyrol, Jérôme, Paillasse, Michaël R., Alet, Nathalie
Publicado 2021

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

por Dagnew, Alemnew F, Klein, Nicola P, Hervé, Caroline, Kalema, George, Di Paolo, Emmanuel, Peterson, James, Salaun, Bruno, Schuind, Anne
Publicado 2020

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine

por Callegaro, Andrea, Burny, Wivine, Hervé, Caroline, Hyung Kim, Joon, Levin, Myron J, Zahaf, Toufik, Cunningham, Anthony L, Didierlaurent, Arnaud M
Publicado 2021

2776. Post-marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Review of Spontaneous Reports Since Introduction

por Tavares-Da-Silva, Fernanda, Miranda Co, Maribel, Dessart, Cristophe, Hervé, Caroline, López-Fauqued, Marta, Mahaux, Olivia, Van Holle, Lionel, Stegmann, Jens-Ulrich
Publicado 2019

26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis

por Callegaro, Andrea, Willer, David O, Burny, Wivine, Hervé, Caroline, Kim, Joon Hyung, levin, myron J, Zahaf, Toufik, Cunningham, Anthony L, Didierlaurent, Arnaud
Publicado 2021

2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine

por Schmader, Kenneth E, Levin, Myron J, Chen, Michael, Matthews, Sean, Riley, Megan, Woo, Wayne, Hervé, Caroline, Grupping, Katrijn, Schuind, Anne, Oostvogels, Lidia, Curran, Desmond
Publicado 2019

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-...

por Mrkvan, Tomas, Campora, Laura, Catteau, Grégory, Douha, Martine, Grupping, Katrijn, Herve, Caroline, Kalema, George, Heineman, Thomas, Klein, Nicola P, Lal, Himal, Oostvogels, Lidia, Schuind, Anne
Publicado 2018

2780. Reactogenicity Profile of Adjuvanted Recombinant Zoster Vaccine after Dose 2 According to the Intensity of the Same Event Experienced after Dose 1

por Colindres, Romulo, Wascotte, Valentine, Brecx, Alain, Clarke, Christopher, Hervé, Caroline, Hyung Kim, Joon, Levin, Myron J, Oostvogels, Lidia, Zahaf, Toufik, Schuind, Anne, Cunningham, Anthony L
Publicado 2019

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials

por Colindres, Romulo, Wascotte, Valentine, Brecx, Alain, Clarke, Christopher, Hervé, Caroline, Kim, Joon Hyung, Levin, Myron J., Oostvogels, Lidia, Zahaf, Toufik, Schuind, Anne, Cunningham, Anthony L.
Publicado 2020

2905. Long-term Immunological Persistence of the Adjuvanted Recombinant Zoster Vaccine: Clinical Data and Mathematical Modeling

por Bastidas, Adriana, Catteau, Grégory, Volpe, Stéphanie, Mrkvan, Tomas, Enemuo, Adaora, Smetana, Jan, Schwarz, Tino, Rombo, Lars, Pauksens, Karlis, Berengier, Estelle, Hervé, Caroline, Oostvogels, Lidia, Schuind, Anne
Publicado 2019

Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults

por Schmader, Kenneth E, Levin, Myron J, Chen, Michael, Matthews, Sean, Riley, Megan E, Woo, Wayne, Hervé, Caroline, Grupping, Katrijn, Schuind, Anne E, Oostvogels, Lidia, Curran, Desmond
Publicado 2020

Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination

por Hastie, Andrew, Catteau, Grégory, Enemuo, Adaora, Mrkvan, Tomas, Salaun, Bruno, Volpe, Stephanie, Smetana, Jan, Rombo, Lars, Schwarz, Tino, Pauksens, Karlis, Hervé, Caroline, Bastidas, Adriana, Schuind, Anne
Publicado 2020

Superior antigen-specific CD4(+)T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older

por Couch, Robert B, Bayas, José M, Caso, Covadonga, Mbawuike, Innocent Nnadi, López, Concepción Núñez, Claeys, Carine, El Idrissi, Mohamed, Hervé, Caroline, Laupèze, Béatrice, Oostvogels, Lidia, Moris, Philippe
Publicado 2014

Regulator of G-Protein Signaling 18 Controls Both Platelet Generation and Function

por Delesque-Touchard, Nathalie, Pendaries, Caroline, Volle-Challier, Cécile, Millet, Laurence, Salel, Véronique, Hervé, Caroline, Pflieger, Anne-Marie, Berthou-Soulie, Laurence, Prades, Catherine, Sorg, Tania, Herbert, Jean-Marc, Savi, Pierre, Bono, Françoise
Publicado 2014

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

por Coccia, Margherita, Collignon, Catherine, Hervé, Caroline, Chalon, Aurélie, Welsby, Iain, Detienne, Sophie, van Helden, Mary J., Dutta, Sheetij, Genito, Christopher J., Waters, Norman C., Van Deun, Katrijn, Smilde, Age K., van den Berg, Robert A., Franco, David, Bourguignon, Patricia, Morel, Sandra, Garçon, Nathalie, Lambrecht, Bart N., Goriely, Stanislas, van der Most, Robbert, Didierlaurent, Arnaud M.
Publicado 2017

Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

por Coccia, Margherita, Collignon, Catherine, Hervé, Caroline, Chalon, Aurélie, Welsby, Iain, Detienne, Sophie, van Helden, Mary J., Dutta, Sheetij, Genito, Christopher J., Waters, Norman C., Van Deun, Katrijn, Smilde, Age K., van den Berg, Robert A., Franco, David, Bourguignon, Patricia, Morel, Sandra, Garçon, Nathalie, Lambrecht, Bart N., Goriely, Stanislas, van der Most, Robbert, Didierlaurent, Arnaud M.
Publicado 2018